Daily Equity Roster
Published: March 24, 2026
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Today's featured stock is GlaxoSmithKline Plc. (United Kingdom) ADR (GSK).

 

Long Ideas

Symbol Company Sector Current Price Action Price Target Stop Notes
WBS Webster Financial Corporation Banks $69.34 hi 60s - low 70s 91 58 4 for 5'er, top 25% of BANK sector matrix, one box from peer RS buy, buy on pullback, 2.2% yield
CGON CG Oncology, Inc. Biomedics/Genetics $64.88 hi 50s - low 60s 80 50 5 for 5'er, 18 of 162 in BIOM sector matrix, bullish catapult, good R-R, Earn. 3/26
COCO Vita Coco Company, Inc. Food Beverages/Soap $55.77 mid-to-hi 50s 72 48 5 for 5'er, top half of FOOD sector matrix, LT pos peer & mkt RS, pos trend flip
DGII Digi International Inc Telephone $49.68 upper 40s to lower 50s 61 40 5 for 5'er; top quartile of Telephone matrix; buy signal since May '25, pos. trend since June '25.
BRX Brixmor Property Group Inc Real Estate $28.84 hi 20s - lo 30s 38 24 4 for 5'er, top third of REAL sector matrix, LT pos peer & mkt RS, LT pos trend, bullish triangle, 4% yield
CNX CNX Resources Corp Oil $40.64 hi 30s - mid 40s 71 33 5 TA rating, top 50% of OIL sector matrix, LT RS buy and pos trend, consec buy signals
FFIV F5 Inc. Internet $289.75 280s - 290s 344 256 4 for 5'er, top third of INET sector matrix, LT pos peer RS, spread quad top
INVA Innoviva, Inc Drugs $21.91 lo-mid 20s 32.50 18.50 5 TA rating, top half of drugs sector RS matrix, LT pos trend, LT RS buy, buy-on-pullback
ORKA Oruka Therapeutics Inc. Biomedics/Genetics $41.56 mid-to-hi 30s 57 30 5 for 5'er, top 10% of BIOM sector marix, quadruple top, buy on pullback, R-R>2.0
ARCB ArcBest Corp. Transports/Non Air $92.00 low-to-mid 90s 113 79 4 for 5'er, one box from market RS buy, top half of favored TRAN sector matrix, good R-R
GSK GlaxoSmithKline Plc. (United Kingdom) ADR Drugs $51.99 hi 40s - mid 50s 67 42 5 TA rating, top 25% of DRUG sector matrix, LT pos trend, yield > 3%, buy-on-pullback

Short Ideas

Symbol Company Sector Current Price Action Price Target Stop Notes
CPRT Copart Incorporated Autos and Parts $33.39 hi 30s 28 42 1 TA rating, bottom 50% of AUTO sector matrix, NT and mkt RS sell last month, consec sell signals

Removed Ideas

Symbol Company Sector Current Price Action Price Target Stop Notes
CACI CACI International Inc. Computers $589.28     528 Moved to a sell signal. Current exposure may maintain $528 stop.
RTX RTX Corp. Aerospace Airline $194.82     166 Moved to a sell signal. Current exposure may maintain $166 stop.
ASND Ascendis Pharma A/S Biomedics/Genetics $218.06     188 Moved to a sell signal. Current exposure may maintain the $188 stop.

Follow-Up Comments

Comment
There are currently no follow-up comments.

NDW Spotlight Stock

 

GSK GlaxoSmithKline Plc. (United Kingdom) ADR ($52.99) R - Drugs - GSK has a 5 for 5 TA rating and sits in the top quartile of the drugs sector RS matrix. The stock moved back to an RS buy signal against the market in February and has been in a positive trend for over a year. The recent chart action saw GSK give a third consecutive buy signal before notching a new multi-year high and then retracting back to the current position below the middle of its trading band. This offers a more opportune entry point for potential long investors. The stock also has a 3.44% yield. Exposure can be considered in the high $40s to mid-$50s. Our initial stop will be positioned at $42, which would violate multiple support levels on the default chart. The bullish price objective of $67 will serve as our price target.

 
          24                 25                 26            
61.00                                                 X       61.00
60.00                                                 X O     60.00
59.00                                                 X O     59.00
58.00                                                 X 3     58.00
57.00                                                 X O     57.00
56.00                                                 X O     56.00
55.00                                                 X O     55.00
54.00                                                 X O   Mid 54.00
53.00                                                 X O     53.00
52.00                                                 2 O     52.00
51.00                                             X   X       51.00
50.00                                             1 O X       50.00
49.00                                             C O X       49.00
48.00                                             B O         48.00
47.00                                             X         Bot 47.00
46.00                                       X   X           46.00
45.00             X                       X O X           45.00
44.00             X O X                     A O X           44.00
43.00         3   5 O X O                   X O             43.00
42.00       2 O X 6 X O               6   X               42.00
41.00       X O X O 8 9 X             X O 9             41.00
40.00       X 4   O X A X O   X   X   X O 8             40.00
39.00       X     O X O X O     3 O X O X O X             39.00
38.00 X   X   1     7 O O     X O X O X O X             38.00
37.00 4 O 9 O C         O     X 4 X 5   7 X             37.00
36.00 X O X O X           B C   2 O X     O               36.00
35.00 X 5 X A X           O X O X O X                   35.00
34.00   O   B             O X O X O X                     34.00
33.00                   O   1 X O                       33.00
32.00                         O                         32.00
          24                 25                 26            

 

Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-2026 Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright